Archives of Medical Science (Sep 2021)

Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection

  • Marilisa Bove,
  • Federica Fogacci,
  • Silvia Quattrocchi,
  • Maddalena Veronesi,
  • Arrigo F.G. Cicero

DOI
https://doi.org/10.5114/aoms/141502
Journal volume & issue
Vol. 17, no. 6
pp. 1797 – 1799

Abstract

Read online

Introduction There is growing attention towards the possible long-term effect of COVID-19 on neuropsychiatric disorders. Material and methods We tested the effect of a combined nutraceutical (Synaid) with known nootropic effects in 40 elderly patients with self-perceived cognitive decline after SARS-CoV-2 infection, treated at home or in hospital. Results After 3 months of treatment, Synaid significantly improved functional status, MMSE and the main psychological disorders associated with mild cognitive impairment, both in patients previously cared for at home and in hospital because of SARS-CoV-2 infection. Conclusions Synaid was well tolerated and effective in improving cognitive function and psychosocial parameters after SARS-CoV-2 infection.

Keywords